Responses
Clinical/translational cancer immunotherapy
Original research
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization
Compose a Response to This Article
Other responses
No responses have been published for this article.
